Stability of first trimester placental growth factor in serum and whole blood

Prenatal Diagnosis

Volumn 31, Issue 12, 2011, Pages 1193-1197

  Cowans, N J ^a   Alfthan, H ^b   Stenman, U H ^b   Spencer, K ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

PLGF; Pre eclampsia; Screening; Stability

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FREEZE THAWING; HUMAN; HUMAN EXPERIMENT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; REFRIGERATOR; STORAGE TEMPERATURE; TEMPERATURE MEASUREMENT;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PROTEIN STABILITY; REGRESSION ANALYSIS;

EID: 82255179129     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2894     Document Type: Article

References (20)

1. AbouZahr C. 2003. Global burden of maternal death and disability. Br Med Bull 67: 1-11.
2. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor at 11+0 to 13+6weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 732-739.
3. Anderson G, Scott M. 1991. Determination of product shelf life and activation energy for five drugs of abuse. Clin Chem 37: 398-402.
4. Bdolah Y, Karumanchi SA, Sachs BP. 2005. Recent advances in understanding of preeclampsia. Croat Med J 46: 728-736.
5. Brosens IA, Robertson WB, Dixon HG. 1972. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1: 177-191.
6. Bujold E, Roberge S, Lacasse Y, et al. 2010. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116: 402-414.
7. Cao Y, Ji WR, Qi P, Rosin A, Cao Y. 1997. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 235: 493-498.
8. Christinger HW, Fuh G, de Vos AM, Wiesmann C. 2004. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J Biol Chem 279: 10382-10388.
9. Cowans NJ, Stamatopoulou A, Hellstrom J, Makela MM, Spencer K. 2010. PAPP-A and free beta-hCG stability in first trimester serum using PerkinElmer AutoDELFIA and DELFIA Xpress systems. Prenat Diagn 30: 127-132.
10. Cuckle HS. 2011. Screening for pre-eclampsia--lessons from aneuploidy screening. Placenta 32(Suppl): S42-S48.
11. Erez O, Romero R, Espinoza J, et al. 2008. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 21: 279-287.
12. Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA. 2000. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 80: 443-454.
13. Iyer S, Leonidas DD, Swaminathan GJ, et al. 2001. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem 276: 12153-12161.
14. Lam C, Lim KH, Karumanchi SA. 2005. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46: 1077-1085.
15. Law LW, Sahota DS, Chan LW, Chen M, Lau TK, Leung TY. 2010. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med 23: 1475-1480.
16. Maglione D, Guerriero V, Viglietto G, et al. 1993. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8: 925-931.
17. Maynard SE, Min JY, Merchan J, et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
18. Nagamatsu T, Fujii T, Kusumi M, et al. 2004. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145: 4838-4845.
19. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. 2001. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184: 1267-1272.
20. Tjoa ML, van Vugt JM, Mulders MA, Schutgens RB, Oudejans CB, van WI. 2001. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 98: 600-607.